It is a key domain for transactivation and transrepression of PPARγ target genes that play important roles in adipogenesis, insulin sensitization, lipid metabolism, and inflammation, making PPARγ an effective target for the management of metabolic diseases, such as type 2 diabetes, obesity, and atherosclerosis [22,45]. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.